These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1152343)

  • 1. [Dosage and elimination of Dextran 40 in patients on hemodialysis (author's transl)].
    Köhler H; Weihrauch TR; Fiegel P; Kirch W; Höffler D
    Klin Wochenschr; 1975 Jun; 53(11):523-7. PubMed ID: 1152343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacocinetics and dosage of dextran 40 in relation to renal function (author's transl)].
    Köhler H; Kirch W; Höffler D; Koeppe P
    Klin Wochenschr; 1974 Dec; 52(23):1111-6. PubMed ID: 4444228
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulant efficacy of PEG-Hirudin in patients on maintenance hemodialysis.
    Pöschel KA; Bucha E; Esslinger HU; Ulbricht K; Nörtersheuser P; Stein G; Nowak G
    Kidney Int; 2004 Feb; 65(2):666-74. PubMed ID: 14717940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prophylaxis and therapy of shunt thrombosis in terminal renal insufficiency (author's transl)].
    Köhler H
    Klin Wochenschr; 1977 Jan; 55(2):49-56. PubMed ID: 834017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypotension and closure of hemodialysis access shunts.
    Berger A; Rosenberg N
    Am Surg; 1983 Oct; 49(10):551-3. PubMed ID: 6205618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse events in chronic hemodialysis patients receiving intravenous iron dextran--a comparison of two products.
    McCarthy JT; Regnier CE; Loebertmann CL; Bergstralh EJ
    Am J Nephrol; 2000; 20(6):455-62. PubMed ID: 11146312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of nomifensine in impaired renal function.
    Ringoir S; Lameire N; Munche M; Heptner W; Taeuber K
    Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):129S-134S. PubMed ID: 334214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.
    Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT
    Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clearance of theophylline by hemodialysis in one patient with chronic renal failure.
    Chang DB; Kuo SH; Yang PC; Shen FH; Luh KT
    Chest; 1992 Nov; 102(5):1621-3. PubMed ID: 1424911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination of iohexol, a low osmolar nonionic contrast medium, by hemodialysis in patients with chronic renal failure.
    Waaler A; Svaland M; Fauchald P; Jakobsen JA; Kolmannskog F; Berg KJ
    Nephron; 1990; 56(1):81-5. PubMed ID: 2234253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of amantadine hydrochloride in subjects with normal and impaired renal function.
    Horadam VW; Sharp JG; Smilack JD; McAnalley BH; Garriott JC; Stephens MK; Prati RC; Brater DC
    Ann Intern Med; 1981 Apr; 94(4 pt 1):454-8. PubMed ID: 7212501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience with the Brescia-Cimino-shunt for hemodialysis in 100 patients (author's transl)].
    Kessler E; Fiegel P; Wernitsch W
    Thoraxchir Vask Chir; 1974 Dec; 22(6):655-7. PubMed ID: 4548980
    [No Abstract]   [Full Text] [Related]  

  • 14. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.
    Knupp CA; Hak LJ; Coakley DF; Falk RJ; Wagner BE; Raasch RH; van der Horst CM; Kaul S; Barbhaiya RH; Dukes GE
    Clin Pharmacol Ther; 1996 Nov; 60(5):535-42. PubMed ID: 8941026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of multiple-dose cefoperazone in hemodialysis patients.
    Spyker DA; Richmond JD; Scheld WM; Bolton WK
    Am J Nephrol; 1985; 5(5):355-60. PubMed ID: 4061504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetic considerations in the use of plasma expanders.
    Klotz U; Kroemer H
    Clin Pharmacokinet; 1987 Feb; 12(2):123-35. PubMed ID: 2435442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of a transdermal testosterone system in men with end stage renal disease receiving maintenance hemodialysis and healthy hypogonadal men.
    Singh AB; Norris K; Modi N; Sinha-Hikim I; Shen R; Davidson T; Bhasin S
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2437-45. PubMed ID: 11397836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of hemodialysis on piperacillin pharmacokinetics.
    Heim-Duthoy KL; Halstenson CE; Abraham PA; Matzke GR
    Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):680-4. PubMed ID: 3818147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of ioversol by hemodialysis.
    Ueda J; Furukawa T; Takahashi S; Sakaguchi K
    Acta Radiol; 1996 Sep; 37(5):826-9. PubMed ID: 8915301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetics of trimethoprim and sulfametrol in patients with end stage renal failure and hemodialysis treatment (author's transl)].
    Schmidt P; Korn A; Hitzenberger G; Zazgornik J; Kopsa H; Pils P
    Wien Med Wochenschr; 1980 Feb; 130(4):171-3. PubMed ID: 7376686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.